In Brief: Merck Zocor
Executive Summary
Merck Zocor: Liver function testing for patients on simvastatin now recommended at start of therapy and periodically (such as semi-annually) for first year of therapy. FDA approved the revised recommendations May 23. Bristol-Myers Squibb received clearance in April to remove the recommendation in labeling for Pravachol for testing at six weeks and for semi-annual testing in patients with normal results at 12 weeks ("The Pink Sheet" April 28, In Brief)...